Non-cancer medications for patients with incurable cancer: Time to stop and think?

British Journal of General Practice

Volumn 60, Issue 573, 2010, Pages 243-244

  Hall, Peter S ^a   Lord, Simon R ^b   El Laboudi, Ahmed ^b   Seymour, Matthew T ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPECITABINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRINOTECAN; PRAVASTATIN;

CANCER PALLIATIVE THERAPY; CANCER PATIENT; CARDIOVASCULAR DISEASE; EDITORIAL; HUMAN; HYPERTENSION; LIFE EXPECTANCY; MALIGNANT NEOPLASTIC DISEASE; SECONDARY PREVENTION; UNITED KINGDOM;

CORONARY DISEASE; DRUG INTERACTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIFE EXPECTANCY; NEOPLASMS; PALLIATIVE CARE; TERMINAL CARE; TERMINALLY ILL;

EID: 77951979564     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X483887     Document Type: Editorial

References (10)

1. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333(20): 1301-1307.
2. Levi F, Lucchini F, Negri E, et al. Mortality from major cancer sites in the European Union, 1955-1998. Ann Oncol 2003; 14(3): 490-495.
3. Cancer Research UK. CancerStats: http://info.cancerresearchuk.org/ cancerstats (accessed 5 Mar 2010).
4. Schiller JH, Harrington D, Belani CP, et al Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346(2): 92-98. (Pubitemid 34438899)
5. Price T, Pittman K, Patterson W, et al. Management and survival trends in advanced colorectal cancer. Clin Oncol (R Coll Radiol) 2008; 20(8): 626-630.
6. DeVita VT Jr (ed.). Cancer principles and practice of oncology. 8th edn. Philadelphia, PA: Lippincott Williams and Wilkins, 2008.
7. National Cancer Institute. SEER database: http://seer.cancer.gov/ faststats/index.php (accessed 5 Mar 2010).
8. Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153(5): 578-581. (Pubitemid 23072387)
9. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371(9627): 1839-1847.
10. Kuderer NM, Khorana AA, Lyman GH, Francis CW. A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications. Cancer 2007; 110(5): 1149-1161.